EUVIMEDEUVIMED entdecken
Crossref

Nano Proteolysis Targeting Chimeras (PROTACs) with Anti‐Hook Effect for Tumor Therapy

Ni-Yuan Zhang, Da-Yong Hou, Xing-Jie Hu, Jian-Xiao Liang, Man-Di Wang, Zhang-Zhi Song, Li Yi, Zhi-Jia Wang, Hong-Wei An, Wanhai Xu, Hao Wang iD

Angewandte Chemie International Edition · 11.09.2023 · 62 (37)

DOI: 10.1002/anie.202308049 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 04.08.2023. Verfasst von Ni-Yuan Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience …. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, Neoplasms. Die Arbeit wurde bisher 108-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Proteolysis targeting chimera (PROTAC) is an emerging pharmacological modality with innovated post‐translational protein degradation capabilities. However, off‐target induced unintended tissue effects and intrinsic “hook effect” hinder PROTAC biotechnology to be maturely developed. Herein, an intracellular fabricated nano proteolysis targeting chimeras (Nano‐PROTACs) modality with a center‐spoke degradation network for achieving efficient dose‐dependent protein degradation in tumor is reported. The PROTAC precursors are triggered by higher GSH concentrations inside tumor cells, which subsequently in situ self‐assemble into Nano‐PROTACs through intermolecular hydrogen bond interactions. The fibrous Nano‐PROTACs can form effective polynary complexes and E3 ligases degradation network with multi‐binding sites, achieving dose‐dependent protein degradation with “anti‐hook effect”. The generality and efficacy of Nano‐PROTACs are validated by degrading variable protein of interest (POI) such as epidermal growth factor receptor (EGFR) and androgen receptor (AR) in a wide‐range dose‐dependent manner with a 95 % degradation rate and long‐lasting potency up to 72 h in vitro. Significantly, Nano‐PROTACs achieve in vivo dose‐dependent protein degradation up to 79 % and tumor growth inhibition in A549 and LNCap xenograft mice models, respectively. Taking advantages of in situ self‐assembly strategy, the Nano‐PROTACs provide a generalizable platform to promote precise clinical translational application of PROTAC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ubiquitin-Protein LigasesNeoplasmsHumansAnimalsMiceProteolysisProteinsBinding Sites

Stichwörter der Autor:innen

NanomedicinePROTACsPeptideSelf-AssemblyTumor

Substanzen

Ubiquitin-Protein LigasesProteins

Autor:innen und Institutionen

  • CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology (NCNST), Beijing, 100190, China.
  • Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing, 100049, P. R. China.
  • Department of Urology, Harbin Medical University Cancer Hospital, Heilongjiang Key Laboratory of Scientific Research in Urology, Harbin, 150001, China.
  • NHC Key Laboratory of Molecular Probes and Targeted Diagnosis and Therapy, Harbin Medical University, Harbin, 150001, China.
  • Henan Institute of Advanced Technology, Zhengzhou University, Zhengzhou, 450052, China.

ORCID-Profile: Hao Wang

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, N. Y., Hou, D. Y., Hu, X. J., Liang, J. X., Wang, M. D., Song, Z. Z., Yi, L., Wang, Z. J., An, H. W., Xu, W., & Wang, H. (2023). Nano Proteolysis Targeting Chimeras (PROTACs) with Anti‐Hook Effect for Tumor Therapy. Angewandte Chemie International Edition, 62(37). https://doi.org/10.1002/anie.202308049

Vancouver

Zhang NY, Hou DY, Hu XJ, Liang JX, Wang MD, Song ZZ, et al. Nano Proteolysis Targeting Chimeras (PROTACs) with Anti‐Hook Effect for Tumor Therapy. Angewandte Chemie International Edition. 2023;62(37). doi:10.1002/anie.202308049

BibTeX
@article{Zhang2023,
  author = {Zhang, Ni-Yuan and Hou, Da-Yong and Hu, Xing-Jie and Liang, Jian-Xiao and Wang, Man-Di and Song, Zhang-Zhi and Yi, Li and Wang, Zhi-Jia and An, Hong-Wei and Xu, Wanhai and Wang, Hao},
  title = {Nano Proteolysis Targeting Chimeras (PROTACs) with Anti‐Hook Effect for Tumor Therapy},
  journal = {Angewandte Chemie International Edition},
  year = {2023},
  volume = {62},
  number = {37},
  doi = {10.1002/anie.202308049}
}
Kostenlos starten →